Cargando…

Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor

Tumors are a serious threat to human health. The oncolytic virus is a kind of tumor killer virus which can infect and lyse cancer cells and spread through the tumor, while leaving normal cells largely unharmed. Mathematical models can help us to understand the tumor-virus dynamics and find better tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Yongmei, Jia, Chen, Chen, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210284/ https://www.ncbi.nlm.nih.gov/pubmed/28097139 http://dx.doi.org/10.1155/2016/5621313

Ejemplares similares

Triple threat to cancer: rationale for combining oncolytic viruses, MEK inhibitors, and immune checkpoint blockade
por: Bommareddy, Praveen K., et al.
Publicado: (2019)

Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus with MEK Inhibitor Trametinib in Some BRAF or KRAS-Mutated Colorectal or Lung Carcinoma Models
por: Zhou, XuSha, et al.
Publicado: (2021)

Chorioallantoic Membrane Tumor Model for Evaluating Oncolytic Viruses
por: Krutzke, Lea, et al.
Publicado: (2020)

Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach
por: Mahasa, Khaphetsi Joseph, et al.
Publicado: (2017)

Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses
por: Liu, Tianyan, et al.
Publicado: (2020)

Inhibition of MEK-ERK pathway enhances oncolytic vaccinia virus replication in doxorubicin-resistant ovarian cancer
por: Lee, Seoyul, et al.
Publicado: (2022)

Tumor Restrictions to Oncolytic Virus
por: Vähä-Koskela, Markus, et al.
Publicado: (2014)

A Dynamical Systems Model for Combinatorial Cancer Therapy Enhances Oncolytic Adenovirus Efficacy by MEK-Inhibition
por: Bagheri, Neda, et al.
Publicado: (2011)

The Oncolytic Virus in Cancer Diagnosis and Treatment
por: Cao, Guo-dong, et al.
Publicado: (2020)

Oncolytic Viruses
por: Chen, Nanhai G., et al.
Publicado: (2012)

Combination immunotherapy with oncolytic vaccinia virus and checkpoint inhibitor following local tumor irradiation
por: Minev, Boris, et al.
Publicado: (2014)

An oncolytic virus–delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment
por: DePeaux, Kristin, et al.
Publicado: (2023)

Cyclical Treatment of Colorectal Tumor Spheroids Induces Resistance to MEK Inhibitors
por: Shahi Thakuri, Pradip, et al.
Publicado: (2018)

Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
por: Hutzen, Brian, et al.
Publicado: (2014)

Combination therapy for cancer with oncolytic virus and checkpoint inhibitor: A mathematical model
por: Friedman, Avner, et al.
Publicado: (2018)

Targeted cancer treatment in silico: small molecule inhibitors and oncolytic viruses
por: Komarova, Natalia L, et al.
Publicado: (2014)

Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment
por: Rosewell Shaw, Amanda, et al.
Publicado: (2018)

Oncolytic Viruses as a Platform for the Treatment of Malignant Brain Tumors
por: de Sostoa, Jana, et al.
Publicado: (2020)

Development and application of oncolytic viruses as the nemesis of tumor cells
por: Zhu, Xiao, et al.
Publicado: (2023)

The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
por: Pierce, Kyle M., et al.
Publicado: (2021)

Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor
por: Küsters-Vandevelde, Heidi VN, et al.
Publicado: (2014)

An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses
por: Wang, Guan, et al.
Publicado: (2020)

Current Development Status of MEK Inhibitors
por: Cheng, Ying, et al.
Publicado: (2017)

Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
por: Everts, Anne, et al.
Publicado: (2020)

Remodeling of Tumor Immune Microenvironment by Oncolytic Viruses
por: Zhang, Bin, et al.
Publicado: (2021)

Tumor Tropism of DNA Viruses for Oncolytic Virotherapy
por: Enow, Junior A., et al.
Publicado: (2023)

MEK inhibitors for the treatment of NRAS mutant melanoma
por: Sarkisian, Saro, et al.
Publicado: (2018)

Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors
por: Oh, Chang-Myung, et al.
Publicado: (2020)

Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma
por: Liu, Xianqiong, et al.
Publicado: (2019)

Oncolytic virus: A catalyst for the treatment of gastric cancer
por: Wang, Junqing, et al.
Publicado: (2022)

Oncolytic Viruses in the Treatment of Bladder Cancer
por: Potts, Kyle G., et al.
Publicado: (2012)

Oncolytic Viruses for Canine Cancer Treatment
por: Sánchez, Diana, et al.
Publicado: (2018)

Modeling the Spatiotemporal Dynamics of Oncolytic Viruses and Radiotherapy as a Treatment for Cancer
por: Simbawa, Eman, et al.
Publicado: (2020)

Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment
por: Wang, Lihong, et al.
Publicado: (2022)

Mathematical modeling of tumor therapy with oncolytic viruses: Regimes with complete tumor elimination within the framework of deterministic models
por: Novozhilov, Artem S, et al.
Publicado: (2006)

Discovery of Novel AKT Inhibitors with Enhanced Anti-Tumor Effects in Combination with the MEK Inhibitor
por: Dumble, Melissa, et al.
Publicado: (2014)

Mathematical modeling of tumor therapy with oncolytic viruses: effects of parametric heterogeneity on cell dynamics
por: Karev, Georgy P, et al.
Publicado: (2006)

New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy
por: Lundstrom, Kenneth
Publicado: (2018)

Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors
por: Megison, Michael L., et al.
Publicado: (2014)

Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
por: LaRocca, Christopher J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_git5j1batbps87uqd005g25aeg